ATE496921T1 - Isoflavonoiddimere - Google Patents
IsoflavonoiddimereInfo
- Publication number
- ATE496921T1 ATE496921T1 AT06721277T AT06721277T ATE496921T1 AT E496921 T1 ATE496921 T1 AT E496921T1 AT 06721277 T AT06721277 T AT 06721277T AT 06721277 T AT06721277 T AT 06721277T AT E496921 T1 ATE496921 T1 AT E496921T1
- Authority
- AT
- Austria
- Prior art keywords
- isoflavonoid
- dimers
- treatment
- compounds
- isoflavonoid dimers
- Prior art date
Links
- 229930013032 isoflavonoid Natural products 0.000 title abstract 2
- 235000012891 isoflavonoids Nutrition 0.000 title abstract 2
- 239000000539 dimer Substances 0.000 title 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- -1 isoflavonoid compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Materials For Medical Uses (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2005901475A AU2005901475A0 (en) | 2005-03-24 | Isflavonoid dimers | |
| US66860905P | 2005-04-06 | 2005-04-06 | |
| AU2005905985A AU2005905985A0 (en) | 2005-10-28 | Pain and anti-inflammatory modalities | |
| PCT/AU2006/000395 WO2006099681A1 (en) | 2005-03-24 | 2006-03-24 | Isoflavonoid dimers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE496921T1 true ATE496921T1 (de) | 2011-02-15 |
Family
ID=37023310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06721277T ATE496921T1 (de) | 2005-03-24 | 2006-03-24 | Isoflavonoiddimere |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US20090131513A1 (de) |
| EP (3) | EP2526941A1 (de) |
| JP (2) | JP2008533177A (de) |
| CN (2) | CN101184756B (de) |
| AT (1) | ATE496921T1 (de) |
| AU (2) | AU2006227555A1 (de) |
| CA (2) | CA2602549A1 (de) |
| DE (1) | DE602006019832D1 (de) |
| ES (1) | ES2360130T3 (de) |
| IL (2) | IL186218A0 (de) |
| MX (1) | MX2007011493A (de) |
| NO (2) | NO20075368L (de) |
| NZ (2) | NZ561574A (de) |
| WO (2) | WO2006108212A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2010029995A1 (ja) * | 2008-09-11 | 2012-02-02 | 協和発酵キリン株式会社 | 疼痛治療剤 |
| JP6115303B2 (ja) * | 2012-05-18 | 2017-04-19 | Jnc株式会社 | 隣接基としてカルボニル基を有するフェノール化合物およびその用途 |
| KR101533197B1 (ko) * | 2014-09-18 | 2015-07-02 | 성균관대학교산학협력단 | 부테인을 포함하는 부종의 예방 또는 치료용 조성물 |
| KR101539180B1 (ko) * | 2014-09-18 | 2015-07-24 | 성균관대학교산학협력단 | 플라보노이드계 화합물을 포함하는 림프부종의 예방 또는 치료용 조성물 |
| US10160740B2 (en) | 2015-03-20 | 2018-12-25 | The Board Of Trustees Of The Leland Stanford Junior University | Carbonate-promoted carboxylation reactions for the synthesis of valuable organic compounds |
| CA3058492A1 (en) | 2016-04-06 | 2017-10-12 | Noxopharm Limited | Radiotherapy improvements |
| JP2019513828A (ja) | 2016-04-06 | 2019-05-30 | ノクソファーム リミティド | 改善された薬物動態を有するイソフラボノイド組成物 |
| RU2649119C1 (ru) * | 2017-02-27 | 2018-03-29 | Федеральное государственное бюджетное учреждение науки Иркутский институт химии им. А.Е. Фаворского Сибирского отделения Российской академии наук (ИрИХ СО РАН) | Средство для профилактики и лечения язвенного колита |
| WO2019051548A1 (en) * | 2017-09-15 | 2019-03-21 | Norbio No. 2 Pty Ltd | TREATMENT OF NEURO-INFLAMMATION |
| WO2020051644A1 (en) * | 2018-09-13 | 2020-03-19 | Norbio No. 2 Pty Ltd | Treatment of peripheral nervous tissue inflammation |
| AU2021247415A1 (en) | 2020-03-30 | 2022-09-29 | Noxopharm Limited | Methods for the treatment of inflammation associated with infection |
| WO2021195698A1 (en) * | 2020-03-30 | 2021-10-07 | Noxopharm Limited | Methods for the treatment of inflammation associated with infection |
| CN118373794B (zh) * | 2024-04-17 | 2025-08-29 | 中国中医科学院中药研究所 | 一种异黄酮类化合物及其制备方法和在制药中的应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0967362A (ja) | 1995-09-01 | 1997-03-11 | Sankyo Co Ltd | ５α−還元酵素阻害剤ビスイソフラボン類 |
| AUPO203996A0 (en) * | 1996-08-30 | 1996-09-26 | Novogen Research Pty Ltd | Therapeutic uses |
| CA2309711C (en) * | 1997-11-11 | 2003-09-16 | Nikken Chemicals Co., Ltd. | N-hydroxyurea derivative and pharmaceutical composition containing the same |
| EP1173164A2 (de) * | 1999-04-16 | 2002-01-23 | AstraZeneca AB | Estrogen beta-rezeptor liganden |
| AUPQ266199A0 (en) * | 1999-09-06 | 1999-09-30 | Novogen Research Pty Ltd | Compositions and therapeutic methods involving isoflavones and analogues thereof |
| JP2004521856A (ja) * | 2000-05-15 | 2004-07-22 | メルク フロスト カナダ アンド カンパニー | Ｃｏｘ−２選択的阻害剤およびトロンボキサン阻害剤を用いる併用療法ならびにそのための組成物 |
| AUPR255401A0 (en) * | 2001-01-16 | 2001-02-08 | Novogen Research Pty Ltd | Regulation of lipids and/or bone density and compositions therefor |
| AUPR363301A0 (en) * | 2001-03-08 | 2001-04-05 | Novogen Research Pty Ltd | Dimeric isoflavones |
| JP4256679B2 (ja) * | 2001-03-16 | 2009-04-22 | ノボゲン リサーチ ピーティーワイ リミテッド | 再狭窄の治療方法 |
| CN1398586A (zh) * | 2001-07-26 | 2003-02-26 | 中国人民解放军军事医学科学院放射医学研究所 | 新的取代庚酸衍生物治疗支气管哮喘和慢性阻塞性肺病 |
| AUPR846401A0 (en) * | 2001-10-25 | 2001-11-15 | Novogen Research Pty Ltd | 6-Hydroxy isoflavones, derivatives and medicaments involving same |
| AU2002952453A0 (en) * | 2002-11-01 | 2002-11-21 | Novogen Research Pty Ltd | Aminated isoflavonoid derivatives and uses thereof |
| JP2007525485A (ja) * | 2003-11-19 | 2007-09-06 | ノボゲン リサーチ ピーティーワイ リミテッド | 複合的な放射線治療及び化学治療の組成物及び方法 |
| EP2407462B1 (de) * | 2004-09-21 | 2014-07-30 | Marshall Edwards, Inc. | Substituierte Chromanderivate, Medikamente und therapeutische Verwendung |
-
2006
- 2006-03-24 AT AT06721277T patent/ATE496921T1/de not_active IP Right Cessation
- 2006-03-24 ES ES06721277T patent/ES2360130T3/es not_active Expired - Lifetime
- 2006-03-24 AU AU2006227555A patent/AU2006227555A1/en not_active Abandoned
- 2006-03-24 NZ NZ561574A patent/NZ561574A/xx not_active IP Right Cessation
- 2006-03-24 AU AU2006235194A patent/AU2006235194A1/en not_active Abandoned
- 2006-03-24 WO PCT/AU2006/000407 patent/WO2006108212A1/en not_active Ceased
- 2006-03-24 JP JP2008502192A patent/JP2008533177A/ja active Pending
- 2006-03-24 WO PCT/AU2006/000395 patent/WO2006099681A1/en not_active Ceased
- 2006-03-24 NZ NZ561573A patent/NZ561573A/en not_active IP Right Cessation
- 2006-03-24 CA CA002602549A patent/CA2602549A1/en not_active Abandoned
- 2006-03-24 EP EP12169609A patent/EP2526941A1/de not_active Withdrawn
- 2006-03-24 MX MX2007011493A patent/MX2007011493A/es unknown
- 2006-03-24 CN CN2006800184282A patent/CN101184756B/zh not_active Expired - Fee Related
- 2006-03-24 US US11/909,581 patent/US20090131513A1/en not_active Abandoned
- 2006-03-24 EP EP06721289A patent/EP1861090A4/de not_active Withdrawn
- 2006-03-24 DE DE602006019832T patent/DE602006019832D1/de not_active Expired - Lifetime
- 2006-03-24 JP JP2008502191A patent/JP2008537545A/ja active Pending
- 2006-03-24 US US11/909,538 patent/US7700644B2/en not_active Expired - Fee Related
- 2006-03-24 CN CN2006800146261A patent/CN101203219B/zh not_active Expired - Fee Related
- 2006-03-24 CA CA002602541A patent/CA2602541A1/en not_active Abandoned
- 2006-03-24 EP EP06721277A patent/EP1861402B1/de not_active Expired - Lifetime
-
2007
- 2007-09-24 IL IL186218A patent/IL186218A0/en unknown
- 2007-09-24 IL IL186217A patent/IL186217A0/en unknown
- 2007-10-19 NO NO20075368A patent/NO20075368L/no not_active Application Discontinuation
- 2007-10-19 NO NO20075367A patent/NO20075367L/no not_active Application Discontinuation
-
2011
- 2011-11-11 US US13/295,014 patent/US20120059176A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1861090A4 (de) | 2010-01-06 |
| EP2526941A1 (de) | 2012-11-28 |
| NZ561573A (en) | 2010-05-28 |
| HK1119557A1 (en) | 2009-03-13 |
| WO2006108212A1 (en) | 2006-10-19 |
| JP2008533177A (ja) | 2008-08-21 |
| AU2006235194A1 (en) | 2006-10-19 |
| CA2602541A1 (en) | 2006-09-28 |
| EP1861090A1 (de) | 2007-12-05 |
| NZ561574A (en) | 2010-03-26 |
| CN101203219A (zh) | 2008-06-18 |
| ES2360130T3 (es) | 2011-06-01 |
| MX2007011493A (es) | 2008-04-14 |
| US20080306140A1 (en) | 2008-12-11 |
| CN101184756B (zh) | 2011-08-03 |
| AU2006227555A1 (en) | 2006-09-28 |
| US7700644B2 (en) | 2010-04-20 |
| EP1861402B1 (de) | 2011-01-26 |
| US20090131513A1 (en) | 2009-05-21 |
| CN101184756A (zh) | 2008-05-21 |
| NO20075367L (no) | 2007-11-27 |
| JP2008537545A (ja) | 2008-09-18 |
| IL186218A0 (en) | 2008-01-20 |
| CA2602549A1 (en) | 2006-10-19 |
| EP1861402A4 (de) | 2009-12-30 |
| CN101203219B (zh) | 2011-06-15 |
| EP1861402A1 (de) | 2007-12-05 |
| NO20075368L (no) | 2007-12-11 |
| US20120059176A1 (en) | 2012-03-08 |
| DE602006019832D1 (de) | 2011-03-10 |
| IL186217A0 (en) | 2008-08-07 |
| WO2006099681A1 (en) | 2006-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20075367L (no) | Isoflavonoide dimerer | |
| DE602006018057D1 (de) | Substituierte chinolone und verwendungsverfahren | |
| CR20130455A (es) | Composiciones para el tratamiento de tumores | |
| CY1122522T1 (el) | Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος | |
| NO20081636L (no) | FAP - inhibitorer | |
| CY1109985T1 (el) | Αναστολεις πρωτεασωματος και μεθοδοι χρησης αυτων | |
| ATE434620T1 (de) | Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen | |
| CL2008002042A1 (es) | Compuestos derivados de heterociclos nitrogenados enlazados; y su uso en el tratamiento de la diabetes y desordenes metabolicos. | |
| DE602005023172D1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
| NO20071127L (no) | Triazoloftalaziner | |
| EA201101085A1 (ru) | Феноксиуксусные кислоты в качестве активаторов ppar дельта | |
| BRPI0607379B8 (pt) | composição farmacêutica de efeito analgésico | |
| CY1113916T1 (el) | Παραγωγα ετεροαρυλο πυρρολιδινυλο και πιπεριδινυλο κετονης | |
| CY1109992T1 (el) | Παραγωγα του αλφα-αμιναμιδιου χρησιμα ως αντιφλεγμονωδη μεσα | |
| CY1111762T1 (el) | Διενυδρη παμοϊκη ολανζαπiνη | |
| BRPI0509660A (pt) | compostos de beta-carbolina de utilidade no tratamento de doenças inflamatórias | |
| ATE548035T1 (de) | Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat | |
| ITRM20050179A1 (it) | Composizione impiegabile per il trattamento delle patologie paradontali. | |
| ATE527996T1 (de) | Medizinische verwendung von 3-(2,2,2- trimethylhydrazinium)propionat-orotat | |
| EP2216043A4 (de) | Verwendung von induktormitteln gse24.2 zur herstellung pharmazeutischer zusammensetzungen zur behandlung von erkrankungen in zusammenhang mit zellseneszenz | |
| IL185653A (en) | Antibodies that call for the 1-kim salt region | |
| FI20040180L (fi) | Koostumus psoriasis-taudin hoitamiseksi | |
| ATE526968T1 (de) | Zusammensetzungen zur behandlung von vaginalen infektionen mit chronischer entzündung | |
| DE112006002215A5 (de) | Proteinzusammensetzung zur Behandlung von Proteinmangelzuständen | |
| CY1114753T1 (el) | Παραγωγα αμινοθειαζολιου και οι χρησεις τους ως αντιβακτηριακοι παραγοντες |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |